CME
Optimizing Treatment and Patient Selection in BRAF V600E-Mutated Metastatic Colorectal Cancer
Host: Julien Taieb, MD, PhD
Guest: Scott Kopetz, MD, PhD
BRAF mCRC is a very aggressive subset of colon cancer and, until recently, treatment options have been very limited. With a new standard of care on the rise, a critical challenge remains: How